LSC
IMMU

Lyon Street Capital’s Immunomedics Inc IMMU Stock Holding History

Lyon Street Capital’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-252,855
Closed -$3.69M – 61
2018
Q1 		$3.69M Sell
252,855
-193,848
-43% -$3.17M 1.19% 28
2017
Q4 		$7.22M Buy
446,703
+296,703
+198% +$3.5M 2.41% 13
2017
Q3 		$2.1M Buy
+150,000
New +$1.49M 0.81% 46

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Lyon Street Capital's IMMU Position: Q2 2018 in Review

Lyon Street Capital sold out of Immunomedics Inc (IMMU) in Q2 2018, closing a stake of 252,855 shares — an estimated $3.69M sold.

Lyon Street Capital first reported a position in IMMU in Q3 2017 and held it in 3 quarters. The position peaked at $7.22M in Q4 2017. 192 funds tracked by Wall St. Rank hold IMMU as of Q2 2018.

  • Lyon Street Capital reported no remaining Immunomedics Inc position as of Q2 2018 after selling out during the quarter.
  • Lyon Street Capital sold 252,855 Immunomedics Inc shares in Q2 2018, an estimated $3.69M.
  • Lyon Street Capital first reported a position in Immunomedics Inc in Q3 2017 and held it in 3 quarters.
  • Lyon Street Capital's Immunomedics Inc position peaked at $7.22M in Q4 2017.
  • 192 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2018.

Based on Lyon Street Capital's 13F filing for Q2 2018, filed 14 Aug 2018.